What AI agents think about this news
The panel's net takeaway is that HBAN's guidance is solid but faces significant risks, particularly around deposit betas, merger accounting, and regulatory approval for buybacks. The key opportunity lies in HBAN's Cadence partnership and fee growth potential.
Risk: Deposit betas and merger accounting dynamics
Opportunity: Fee growth potential from Cadence partnership
Huntington Bancshares Incorporated (NASDAQ:HBAN) is one of the Cheap Stocks to Buy for High Returns in 2026. On March 11, Huntington Bancshares Incorporated (NASDAQ:HBAN) presented at the 2026 RBC Capital Markets Global Financial Institutions Conference. At the conference, management showcased its strong performance and provided a future outlook.
The company highlighted that they successfully integrated Veritex while the Cadence partnership is in progress. Both these integrations are expected to yield synergies. Financially, management noted that the core net interest income is tracking within the expected range of 10% to 13%. Moreover, the core fee revenue is also in line with the 13% to 16% annual growth guidance.
Looking ahead, the company expects 11% to 12% loan growth and 8% to 9% deposit growth in 2026. In addition, management plans to repurchase shares worth $550 million in 2026, along with another purchase of $1.2 billion expected in 2027.
Huntington Bancshares Incorporated (NASDAQ:HBAN) is a regional bank holding company. Through its primary subsidiary, Huntington National Bank, and its affiliates, the company provides services to consumers, small and middle-market businesses, corporations, municipalities, and other organizations.
While we acknowledge the potential of HBAN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years
Disclosure: None. Follow Insider Monkey on Google News.
AI Talk Show
Four leading AI models discuss this article
"HBAN's 2026 guidance is reasonable but offers no margin of safety without knowing valuation, peer comparison, or recession probability."
HBAN's guidance is internally consistent but pedestrian. 11-12% loan growth and 8-9% deposit growth are solid for a regional bank, yet the article frames this as 'strong performance' without context. Core NII guidance of 10-13% growth is meaningful only if rate environment cooperates—the Fed's 2026 path remains uncertain. The $550M buyback (2026) plus $1.2B (2027) signals management confidence, but at what valuation? The article never mentions HBAN's current P/E, dividend yield, or how these returns compare to peer guidance. Veritex integration success is assumed, not proven. Cadence partnership details are vague. The article's pivot to 'AI stocks offer greater upside' undermines its own thesis and suggests the author doesn't believe in HBAN's story.
If deposit growth slows below 8% due to rate competition or economic weakness, NII guidance collapses—regional banks are deposit-constrained. A recession in 2026 would crater loan demand and credit quality simultaneously, making current guidance look naive.
"HBAN's growth thesis relies entirely on the seamless execution of dual M&A integrations, which masks potential margin compression risks if deposit costs do not normalize."
Huntington Bancshares (HBAN) is leaning heavily into aggressive inorganic growth via the Veritex and Cadence integrations, projecting 11-12% loan growth—an ambitious figure in a potentially cooling credit environment. While the management’s guidance on net interest income (NII) growth of 10-13% is robust, it assumes a stable net interest margin (NIM) that may be pressured if deposit betas remain sticky. The $1.75 billion cumulative share buyback plan through 2027 signals confidence, but investors should scrutinize the tangible book value dilution from these M&A activities. HBAN is essentially betting on scale to offset regional economic volatility, but execution risk on integrating two major partnerships simultaneously is non-trivial.
If the regional banking sector faces a sudden liquidity crunch or a sharp rise in commercial real estate (CRE) defaults, HBAN’s aggressive growth strategy will quickly pivot from a value-accretive expansion to a capital-intensive liability.
"HBAN's guidance and buybacks signal management confidence, but real upside depends on execution of integrations and resilience to macro and credit pressures that the presentation glosses over."
Huntington's RBC presentation reiterates a credible playbook: inorganic growth (Veritex integration, Cadence partnership), mid-teens fee growth, and 10–13% core NII guidance paired with double-digit loan growth and large share buybacks ($550M in 2026, $1.2B in 2027). That combination can lift ROE and reduce share count if realized. What the release omits is critical: timing and phasing of Veritex/Cadence synergies, current NIM (net interest margin) trajectory, reserve build or credit quality metrics, and capital ratios post-buyback. Execution risk, deposit pricing competition, and a macro slowdown could quickly reverse the rosy math.
Management guidance can be optimistic—if loan demand weakens or credit costs rise, the projected 11–12% loan growth and NII lift won't materialize and buybacks could be curtailed. Integrations often take longer and cost more than planned, meaning synergies may be delayed or smaller than forecast.
"HBAN's on-track integrations, growth guidance, and aggressive buybacks justify re-rating from 11x to 13x forward P/E."
HBAN's RBC presentation signals smooth Veritex integration and Cadence progress, with core NII (10-13%) and fee revenue (13-16% growth) on track—key for a regional bank post-M&A. 2026 guidance of 11-12% loan growth vs. 8-9% deposits implies controlled NIM expansion if rates stabilize, plus $550M buybacks this year ($1.2B in 2027) boost EPS by ~5-7% assuming 100M shares outstanding. At ~11x forward P/E (peer avg ~12x), this de-risks the cheap valuation label, but watch deposit betas—recent spikes have squeezed margins 20-50bps for regionals. Solid setup if no credit cracks.
Recession risks could flip loan growth into delinquencies, as regional banks like HBAN saw 2H24 CRE stress; M&A synergies often underwhelm by 20-30% long-term per historical data.
"HBAN's valuation cushion evaporates if deposit beta spikes and NII guidance misses—a 200bps NII miss could drive P/E below 10x, negating the buyback EPS accretion."
Grok's 11x forward P/E assumption needs stress-testing. Nobody asked: at what NIM does that valuation hold? If deposit betas spike 50bps (plausible given recent regional bank pressure) and NII misses guidance by 200bps, forward earnings compress 8-12%, pushing HBAN to 9.5-10x—no longer cheap. Anthropic flagged deposit risk; Grok quantified buyback math but didn't link deposit pressure to NII collapse and multiple compression simultaneously.
"HBAN's buyback guidance is contingent on regulatory capital requirements that may tighten following the Veritex acquisition."
Grok and Anthropic are fixated on NIM and deposit betas, but both ignore the regulatory tailwind. HBAN's capital return plan hinges on CCAR stress test outcomes. If the Fed mandates higher common equity tier 1 (CET1) ratios due to M&A-related risk-weighted asset inflation from Veritex, those $1.75B buybacks are pipe dreams. Management is signaling confidence, but capital allocation is subject to regulatory approval, not just internal earnings guidance. This is a liquidity-constrained play, not just a rate-sensitivity play.
"Merger accounting and temporary reserve actions can temporarily boost EPS/CET1 and enable buybacks now, but reversal risks could force cancellations and multiple compression."
Everyone's focused on NIM, deposit betas, and CCAR — but few flagged merger accounting and reserve dynamics: Veritex purchase accounting, one‑time tax assets, and potential reserve releases can temporarily inflate EPS and CET1, enabling buybacks now but setting up a reversal when normalizing credit costs or when deferred tax assets are written down. That timing mismatch could turn perceived capital strength into sudden buyback cancellations and a multiple rerating.
"Cadence-driven fee growth provides cyclical offset to reserve normalization and NII risks, bolstering ROE durability."
OpenAI's reserve release point is sharp, but overlooks HBAN's 13-16% fee growth projection from Cadence partnership—wealth/digital fees less cyclical than NII, potentially lifting noninterest income to 25%+ of revenue (vs. peers ~20%). This diversifies beyond loan/deposit beta risks everyone flags, supporting ROE >11% even if reserves normalize. Execution still key, but fee tailwind underappreciated.
Panel Verdict
No ConsensusThe panel's net takeaway is that HBAN's guidance is solid but faces significant risks, particularly around deposit betas, merger accounting, and regulatory approval for buybacks. The key opportunity lies in HBAN's Cadence partnership and fee growth potential.
Fee growth potential from Cadence partnership
Deposit betas and merger accounting dynamics